Derek Hennecke is an accomplished leader in the biotechnology and pharmaceutical industries, currently serving as a board member for several innovative companies including Kincell Bio, AVS Bio, Inceptor Bio, Everest Clinical Research, and Grand River Aseptic Manufacturing. As Chairman of the Board at Microsize and Particle Dynamics International, Derek Hennecke drives advancements in pharmaceutical technologies and particle size reduction. Formerly the CEO and President of Xcelience, which was successfully sold to Capsugel, Derek has a robust background in operational leadership and strategic guidance. Educational credentials include a Master of Liberal Arts in Biology from Harvard University and an MBA in International Business from the Rotterdam School of Management.
This person is not in the org chart
This person is not in any teams